Sequencing immunotherapy in locally advanced head and neck squamous cell carcinoma: a narrative clinical-translational review
Background Immune checkpoint inhibitors have entered curative-intent treatment of locally advanced head and neck squamous cell carcinoma, but randomized trials have shown divergent results across definitive, perioperative, and postoperative settings. Methods We reviewed pivotal randomized phase II–III trials and key tr...